$5.2+ Billion AI Medical Diagnosis App Market by 2033 at 19.1% CAGR
AI Medical Diagnosis App Market
Allied Market Research published a report, titled, "AI Medical Diagnosis App Market by Application (Radiology, Pathology, Cardiology, Dermatology and Other), Deployment Model (Cloud-based and On-premises), and End User (Hospitals, Diagnostic Centers, Clinics and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the ai medical diagnosis app market was valued at $0.9 billion in 2023, and is estimated to reach $5.2 billion by 2033, growing at a CAGR of 19.1% from 2024 to 2033.
๐๐๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/request-sample/A323964
Prime determinants of growth
Rise in demand for efficient healthcare solutions and shortage of healthcare professionals are the major factors that drive the growth of the AI medical diagnosis app market. However regulatory compliance and data privacy concerns hinder the market growth. Moreover, growth in focus on patient empowerment and demand for personalized medicine offers remunerative opportunities for the expansion of the global AI medical diagnosis app market.
Report coverage & details
Report Coverage
Details
Forecast Period
2024โ2033
Base Year
2023
Market Size in 2023
$0.9 billion
Market Size in 2033
$5.1 billion
CAGR
19.0%
No. of Pages in Report
216
Segments Covered
Application, Deployment Model, End User and Region
Drivers
Rise in demand for efficient healthcare solutions
Shortage of healthcare professionals
Technological integration in healthcare
Opportunities
Patient empowerment and demand for personalized medicine
Restraints
Regulaory compliance and data privacy concerns
Segment Highlights
Prominent application of Radiology in AI Medical Diagnosis App
In the AI medical diagnosis app market, radiology applications are particularly prominent due to the significant advancements in AI algorithms for image analysis. These applications enhance the accuracy and speed of interpreting X-rays, MRIs, and CT scans, aiding in early detection and diagnosis of diseases, thereby improving patient outcomes and efficiency in healthcare.
More use of cloud-based deployment
The AI medical diagnosis app market is increasingly favoring cloud-based deployment model due to its scalability, cost-effectiveness, and accessibility. Cloud solutions enable seamless data storage, sharing, and integration, facilitating real-time updates and remote access for healthcare providers, thus enhancing the efficiency and reach of AI diagnostic tools.
Hospitals the major user of AI Medical Diagnosis App
Hospitals are the primary users of AI medical diagnosis apps, leveraging these tools to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes. By integrating AI into their systems, hospitals can efficiently analyze large volumes of medical data, support clinical decision-making, and provide timely, precise diagnoses.
Regional Outlook
The AI medical diagnosis app market shows significant growth potential across regions. North America leads with advanced healthcare infrastructure and high AI adoption. Europe follows, driven by supportive regulations. Asia-Pacific is rapidly expanding due to increase in healthcare investments and technological advancements, while emerging markets in Latin America and Africa offer promising growth opportunities.
Players
Microsoft NVIDIA Corporation
Merative Intel Corporation
Siemens Healthineers
GE HealthCare
Digital Diagnostics Inc.
Advanced Micro Devices, Inc.
InformAl
HeartFlow, Inc.
Enlitic, Inc.
icometrix
Aidence
Butterfly Network, Inc.
The report provides a detailed analysis of these key players in the global AI medical diagnosis app market. These players have adopted different strategies such as expansion, product approval, product launch and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Recent Industry Development
In March 2022, Qure.ai (Qure), a health-tech business announced raising $40 million in fundraising, for employing artificial intelligence (AI) for medical imaging diagnostics. The funding will accelerate the AI-driven healthcare companyโs market expansion into the global market and support new product development.
In June 2022, Bayer launched Calantic digital solutions to help address radiology industry challenges. The new platform features apps were designed to aid radiologists in managing workloads, detecting lesions, and handling patient management. Bayer enhanced its radiology business's digital capabilities by launching AI-based apps for X-ray, MRI, and CT imaging.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/A323964
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
